Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae
-
Published:2020-10-14
Issue:1
Volume:11
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Vizarraga DavidORCID, Kawamoto AkihiroORCID, Matsumoto U., Illanes RamiroORCID, Pérez-Luque Rosa, Martín Jesús, Mazzolini Rocco, Bierge Paula, Pich Oscar Q.ORCID, Espasa Mateu, Sanfeliu Isabel, Esperalba Juliana, Fernández-Huerta Miguel, Scheffer Margot P., Pinyol Jaume, Frangakis Achilleas S.ORCID, Lluch-Senar Maria, Mori ShigetarouORCID, Shibayama Keigo, Kenri TsuyoshiORCID, Kato TakayukiORCID, Namba KeiichiORCID, Fita Ignacio, Miyata MakotoORCID, Aparicio DavidORCID
Abstract
AbstractMycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections.
Funder
Japan Society for the Promotion of Science London Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference74 articles.
1. Narita, M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J. Infect. Chemother. 16, 162–169 (2010). 2. Ferwerda, A., Moll, H. A. & de Groot, R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur. J. Pediatr. 160, 483–491 (2001). 3. Atkinson, T. P., Balish, M. F. & Waites, K. B. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol. Rev. 32, 956–973 (2008). 4. Parrott, G. L., Kinjo, T. & Fujita, J. A compendium for Mycoplasma pneumoniae. Front. Microbiol. 7, 513 (2016). 5. Radestock, U. & Bredt, W. Motility of Mycoplasma pneumoniae. J. Bacteriol. 129, 1495–1501 (1977).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|